Signals
Schizophrenia’s Missing Symptoms Move Onto the Phone
A Phase III randomised trial found that a smartphone therapeutic improved motivation and pleasure-related negative symptoms of schizophrenia. The significance is not that an app replaces psychiatry. It is that psychiatry may finally be treating what medication often leaves behind.
Cancer Sequencing Becomes the Operating System of Precision Oncology
Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease
A new Lp(a) threshold could reshape cardiovascular risk assessment
The next cardiometabolic battleground is ultra-processed food
ADA 2026 findings show diabetes drugs are no longer just chasing glucose
Oral SERDs Face the Hard Test: Where Do They Actually Fit?
Prostate Cancer Value Starts Counting Cognition
The ASCO Drug Race Still Runs Through Genomic Testing
Alzheimer’s Blood Testing Moves the Disease Clock Earlier
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.